Credo Health, based in Denver, Secures $5.25 million in seed funding. FirstMile Ventures, Hannah Grey VC, and Springtime Ventures were among the current investors in the round, which was headed by FCA Venture Partners.
The company plans to use the money to grow its sales force, improve its technology infrastructure, and keep pushing innovation in the value-based care industry.
Read also – Tenn-based Reimagine Care Secures an Investment
Under the leadership of its founder and CEO, Carm Huntress, Credo Health offers a PreDx product that uses AI-enabled analysis of digital medical records to offer a pre-encounter risk analysis, clinical summaries, and HEDIS Gap Closure. This allows healthcare providers to provide more individualised care and make better clinical decisions.
To make sure clinicians have access to every patient’s full clinical record, Credo Health combines human expertise and AI-driven analysis with manual and digital medical record retrieval.
Read also – Cambridge-based Ceretype Neuromedicine Secures its Second Round of Seed Funding
About Credo Health
Credo’s platform for retrieving and analysing medical records collects and condenses the data required by value-based care organisations to provide superior care, precisely adjust for risk, and achieve better reimbursement results right away.
Read also – Moonwalk Biosciences Raises $57 Mn Seed and Series A Funding
